Blue Ocean Capital completes exit from China Cord Blood

Chinese private equity firm Blue Ocean Capital has exited from NYSE-listed China Cord Blood Corporation, in which it invested $250 million in 2015.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe